Skip to main content
生物谷 logo

生物谷 — Investor Relations & Filings

Ticker · 920266 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2022-07-06 Governance Information
Country CN China
Listing Beijing Stock Exchange 920266

About 生物谷

https://www.bioon.com/

Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.

Recent filings

Filing Released Lang Actions
公司章程
Governance Information Classification · 100% confidence The document is titled as the "公司章程" which translates to "Company Articles of Association" or "Company Bylaws." It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, and governance rules. It references Chinese company law, securities law, and stock exchange regulations. The content is a comprehensive governance document outlining the internal rules and procedures of the company rather than financial results, audit opinions, or announcements. It is not a report of financial performance, nor an announcement of voting results or management changes. It fits the definition of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2022-07-06 Chinese
第四届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the sixth meeting of the fourth board of directors of Yunnan Biological Valley Pharmaceutical Co., Ltd. It details meeting attendance, agenda items, voting results, and references other announcements related to board member resignations and appointments. The content focuses on changes in the company's board of directors and related governance matters. It is not a full report, financial statement, or earnings release, but rather a board/management information announcement about director changes and meeting resolutions. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length is under 5,000 characters and contains substantive content about board decisions, not just a notice or report publication announcement.
2022-07-06 Chinese
董事、监事辞职公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the resignation of several board members and supervisors of the company, including details about their shareholdings, resignation reasons, and the impact on the company. It does not contain financial data, audit information, or detailed reports but focuses on changes in the company's board and management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2022-07-06 Chinese
独立董事候选人声明公告（张倩芸）
Regulatory Filings Classification · 95% confidence The document is a formal declaration by an independent director candidate, Zhang Qianyun, confirming qualifications and independence according to various regulatory requirements and company rules. It includes detailed statements about compliance with laws, regulations, and stock exchange rules, but does not contain financial data, financial results, or any report of company performance. It is not an announcement of voting results or a proxy solicitation. It is a regulatory compliance statement related to board membership qualifications. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and attestation documents that do not fit other categories.
2022-07-06 Chinese
董事会关于独立董事候选人符合任职资格的声明
Board/Management Information Classification · 95% confidence The document is a formal announcement from the board of directors of Yunnan Shengwu Gu Pharmaceutical Co., Ltd. regarding the qualifications of independent director candidates. It details the candidates' compliance with legal and regulatory requirements, their independence, and lack of disqualifying records. There is no financial data, no report attached or referenced as published, and no mention of voting results or meeting materials. The content focuses on board/management information, specifically about director qualifications and declarations. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is a standalone announcement, not a report or certification.
2022-07-06 Chinese
独立董事关于第四届董事会第六次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on changes in the company's board of directors, specifically regarding resignations and new appointments of non-independent and independent directors. It references compliance with company law and internal regulations, and it is dated around a board meeting. The content focuses on board composition changes rather than financial results, audit, or other report types. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2022-07-06 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.